S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Clinical trial NCT03499808 · COMPLETED

Trial details

NCT number: NCT03499808
Sponsor: SWOG Cancer Research Network
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Amorphous, Eosinophilic, and Acellular Deposit Constipation Diarrhea Early Satiety Gastrointestinal Hemorrhage Hepatomegaly Lymphadenopathy Macroglossia Nausea Primary Systemic Amyloidosis Purpura Recurrent Primary Amyloidosis

Start date: 2018-06-06
Primary completion: 2023-08-30
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.